CLINICAL_TRIALS
trial_result
· 2016-04-05
Clinical Trial Update: Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia [Phase 1]
Summary
A Phase 1 study evaluating LOP628 in adults with c-KIT–positive solid tumors and acute myeloid leukemia has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: cKIT-positive Solid Tumors, AML | Phase 1 | Status: TERMINATED